Your browser doesn't support javascript.
loading
Family-based association of HLA-DRB1 and DQB1 alleles and haplotypes in a group of Iranian Type 1 diabetes children.
Shirizadeh, Ata; Razavi, Zahra; Saeedi, Vahid; Faradmal, Javad; Roshanaei, Ghodratollah; Hajilooi, Mehrdad; Morahan, Grant; Solgi, Ghasem.
Affiliation
  • Shirizadeh A; Immunology Department, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Razavi Z; Pediatrics Department, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Saeedi V; Pediatric Endocrinology and Metabolism Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Faradmal J; Biostatistics Department, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Roshanaei G; Biostatistics Department, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Hajilooi M; Immunology Department, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Morahan G; Centre for Medical Research, University of Western Australia, Perth, Western Australia, Australia.
  • Solgi G; Immunology Department, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
HLA ; 103(4): e15446, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38575369
ABSTRACT
This family-based study was conducted in a group of Iranians with Type 1 diabetes (T1D) to investigate the transmission from parents of risk and non-risk HLA alleles and haplotypes, and to estimate the genetic risk score for this disease within this population. A total of 240 T1D subjects including 111 parent-child trios (111 children with T1D, 133 siblings, and 222 parents) and 330 ethnically matched healthy individuals were recruited. High-resolution HLA typing for DRB1/DQB1 loci was performed for all study subjects (n = 925) using polymerase chain reaction-sequence-specific oligonucleotide probe method. The highest predisposing effect on developing T1D was conferred by the following haplotypes both in all subjects and in probands compared to controls DRB1*0405-DQB1*0302 (Pc = 2.97e-06 and Pc = 6.04e-10, respectively), DRB1*0402-DQB1*0302 (Pc = 5.94e-17 and Pc = 3.86e-09, respectively), and DRB1*0301-DQB1*0201 (Pc = 8.26e-29 and Pc = 6.56e-16, respectively). Conversely, the major protective haplotypes included DRB1*1301-DQB1*0603 (Pc = 6.99e-08), DRB1*1501-DQB1*0602 (Pc = 2.97e-06) in the cases versus controls. Also, DRB1*0301-DQB1*0201/DRB1*0402|05-DQB1*0302 and DRB1*0301-DQB1*0201/DRB1*0301-DQB1*0201 diplotypes conferred the highest predisposing effect in the cases (Pc = 8.65e-17 and Pc = 6.26e-08, respectively) and in probands (Pc = 5.4e-15 and Pc = 0.001, respectively) compared to controls. Transmission disequilibrium test showed that the highest risk was conferred by DRB1*0402-DQB1*0302 (Pc = 3.26e-05) and DRB1*0301-DQB1*0201 (Pc = 1.78e-12) haplotypes and the highest protection by DRB1*1401-DQB1*0503 (Pc = 8.66e-05), DRB1*1501-DQB1*0602 (Pc = 0.002), and DRB1*1101-DQB1*0301 (Pc = 0.0003) haplotypes. Based on logistic regression analysis, carriage of risk haplotypes increased the risk of T1D development 24.5 times in the Iranian population (p = 5.61e-13). Also, receiver operating characteristic curve analysis revealed a high predictive power of those risk haplotypes in discrimination of susceptible from healthy individuals (area under curve 0.88, p = 5.5e-32). Our study highlights the potential utility of genetic risk assessment based on HLA diplotypes for predicting T1D risk in individuals, particularly among family members of affected children in our population.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Middle Eastern People Limits: Humans Country/Region as subject: Asia Language: En Journal: HLA Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Middle Eastern People Limits: Humans Country/Region as subject: Asia Language: En Journal: HLA Year: 2024 Document type: Article